An American flag with white stars on a blue field and red and white stripes, appears wavy and partially obscured by diagonal and vertical lines, creating a layered, abstract effect.

$500 Billion in New U.S. Biopharmaceutical Investment

PhRMA member companies are investing to fuel innovation and bring new jobs to communities across America. Our new investments will deliver a $1.2 trillion boost to the U.S. economy.

A stylized, digital illustration of a U.S. banknote featuring grid patterns, vibrant blue, orange, and green hues, and abstracted security elements and portraits, symbolizing currency and finance.

Where’s the Drug Dollar Going?

Our current system is inefficient and costs Americans more than it should due to unnecessary bureaucracy. In fact, half of every dollar goes to someone who did not make the medicine.

A group of seven people stand side by side outdoors, smiling, holding shovels at a groundbreaking ceremony. Helmets rest atop the shovels. A modern office building and construction equipment are in the background.

Gilead Boosts U.S. Manufacturing Capacity to Advance Next-Generation Biologics

Gilead’s new Bay Area facility is supporting the American workforce while underscoring its commitment to strengthening U.S. biopharmaceutical leadership.

A wall sign with raised metallic letters reads “Research Triangle Park” against a background of brown bricks and geometric shapes in blue, red, and gray.

North Carolina’s Research Triangle Park is a Powerhouse for Biopharma Innovation and Economic Growth

Decades of investment in North Carolina’s biopharmaceutical industry has spurred the state’s economy, workforce development and community engagement.

A New Era of Biopharmaceutical Innovation

The biopharmaceutical industry is on the brink of unprecedented breakthroughs, with the potential to revolutionize health care, reduce the burden of disease and create a healthier future for all.

Sign up for email updates